Literature DB >> 3497951

Effects of human interleukin 1 and human tumor necrosis factor on human T lymphocyte colony formation.

J R Zucali, G J Elfenbein, K C Barth, C A Dinarello.   

Abstract

The growth of T lymphocyte colonies in agar is dependent on the cooperation of a number of different cell types and their products. Among these interacting cells are monocytes and/or macrophages. Monocytes are capable of producing both interleukin 1 (IL-1) and tumor necrosis factor (TNF). These two factors display a positive influence on T cell colony formation. Recombinant IL-1 and recombinant TNF were both shown to stimulate T cell colony growth in a dose-dependent manner, and this stimulation could be blocked by prior incubation with anti-IL-1 or anti-TNF, respectively. In addition, conditioned medium obtained from monocytes cultured in the presence of endotoxin also stimulated T cell colony formation. This stimulation by monocyte-conditioned medium was partially suppressed by incubation with anti-TNF or anti-IL-1, while incubation with both antibodies together displayed greater suppression. In conclusion, monocytes produce at least two factors, IL-1 and TNF, which can stimulate T cell colony formation by peripheral blood lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497951      PMCID: PMC442302          DOI: 10.1172/JCI113133

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Stimulation and inhibition of human T-lymphocyte colony cell proliferation by hemopoietic cell factors.

Authors:  A Zeevi; I Goldman; L A Rozenszajn
Journal:  Cell Immunol       Date:  1977-02       Impact factor: 4.868

2.  Colony growth of human T lymphocytes in agar: effect of a soluble factor from adherent cells.

Authors:  M H Claësson; S Whittingham; M B Rodger; A W Burgess
Journal:  Eur J Immunol       Date:  1977-09       Impact factor: 5.532

3.  Human leukocytic pyrogen: purification and development of a radioimmunoassay.

Authors:  C A Dinarello; L Renfer; S M Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

4.  Colony formation by human T lymphocytes in agar medium.

Authors:  M H Claësson; M B Rodger; G R Johnson; S Whittingham; D Metcalf
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

5.  Studies on cell interactions using a micromethod for growing T-lymphocyte colonies in agar culture.

Authors:  P Goube De Laforest; P Thomas; D Pelletier; J Tanzer
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

6.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

Review 7.  T-cell growth factor.

Authors:  K A Smith
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

8.  Purification of human monocytes: isolation and collection of large numbers of peripheral blood monocytes.

Authors:  R S Weiner; V O Shah
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

Review 9.  Human T-lymphocyte growth factor: regulation of growth and function of T lymphocytes.

Authors:  F W Ruscetti; R C Gallo
Journal:  Blood       Date:  1981-03       Impact factor: 22.113

10.  Semicontinuous flow centrifugation for the pheresis of immunocompetent cells and stem cells.

Authors:  R S Weiner; C M Richman; R A Yankee
Journal:  Blood       Date:  1977-03       Impact factor: 22.113

View more
  15 in total

Review 1.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

2.  Recombinant human tumor necrosis factor mediates regression of a murine sarcoma in vivo via Lyt-2+ cells.

Authors:  A L Asher; J J Mulé; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  The mononuclear cell infiltrate compared with survival in high-grade astrocytomas.

Authors:  M L Rossi; N R Jones; E Candy; J A Nicoll; J S Compton; J T Hughes; M M Esiri; T H Moss; F F Cruz-Sanchez; H B Coakham
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Gene expression of cytokines suppressing hematopoietic progenitor cells in lymphoid malignancies.

Authors:  C Kawasaki; S Okamura; S Hayashi; S Kondo; M Harada; Y Niho
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

5.  Species-specific TNF induction of thymocyte proliferation.

Authors:  M J Ehrke; R L Ho; K Hori
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

6.  Differential effect of tumour necrosis factor on human thymocyte subpopulations.

Authors:  M A Muñoz-Fernández; F X Pimentel-Muiños; A González; F Gambon; L Alvarez-Vallina; M Fresno
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

Review 7.  The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responses.

Authors:  S Modi; M Soejima; M C Levesque
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

8.  Tumor necrosis factor alpha directly and indirectly regulates hematopoietic progenitor cell proliferation: role of colony-stimulating factor receptor modulation.

Authors:  S E Jacobsen; F W Ruscetti; C M Dubois; J R Keller
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

9.  Blockade of prostaglandin production increases cachectin synthesis and prevents depression of macrophage functions after hemorrhagic shock.

Authors:  W Ertel; M H Morrison; A Ayala; M M Perrin; I H Chaudry
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

10.  Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma.

Authors:  A D Roth; F J Hornicek; C G Gerstner; J M Kirkwood
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.